418 related articles for article (PubMed ID: 21725369)
1. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
2. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
Wang X; Guo H; Yao B; Helms J
Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
[TBL] [Abstract][Full Text] [Related]
3. miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.
Lin Z; Sun L; Chen W; Liu B; Wang Y; Fan S; Li Y; Li J
Cancer Sci; 2014 Oct; 105(10):1288-98. PubMed ID: 25130698
[TBL] [Abstract][Full Text] [Related]
4. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
Zhao Z; Zhang L; Yao Q; Tao Z
Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
[TBL] [Abstract][Full Text] [Related]
5. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
[TBL] [Abstract][Full Text] [Related]
6. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
[TBL] [Abstract][Full Text] [Related]
7. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
8. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
14. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
Jiao J; Zhao X; Liang Y; Tang D; Pan C
Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
[TBL] [Abstract][Full Text] [Related]
15. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
16. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
Lv Z; Yang Y; Yang C
Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer.
Li Z; Wang Y; Yuan C; Zhu Y; Qiu J; Zhang W; Qi B; Wu H; Ye J; Jiang H; Yang J; Cheng J
Lab Invest; 2014 Dec; 94(12):1431-45. PubMed ID: 25286028
[TBL] [Abstract][Full Text] [Related]
18. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
